Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The European Respiratory Journal|June 15, 2000
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropiumJ A van Noord, D R de Munck, T A Bantje, et al.Respiratory Medicine|March 23, 2010
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptomsJ A van Noord, J-L Aumann, E Janssens, et al.Pulmonary Pharmacology & Therapeutics|August 16, 2011
24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPDJ A van Noord, J J Smeets, B M Drenth, et al.The European Respiratory Journal|March 2, 2002
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropiumW Vincken, J A van Noord, A P M Greefhorst, et al.Journal of Clinical Pharmacology|October 30, 2013
Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary diseaseJ M Hohlfeld, A Sharma, J A van Noord, et al.The European Respiratory Journal|August 2, 2005
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDJ A van Noord, J-L Aumann, E Janssens, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 22, 2003
Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic BronchitisM Solèr, H Lode, R Baldwin, et al.Thorax|March 4, 2003
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaD B Price, D Hernandez, P Magyar, et al.The Journal of Allergy and Clinical Immunology|September 14, 1999
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study GroupC Villaran, S J O'Neill, A Helbling, et al.Pageof 4